Today: 30 June 2026
AppLovin (APP) stock price rebounds in New York trade, but SEC probe headline still hangs over shares
24 February 2026
1 min read

AppLovin (APP) stock price rebounds in New York trade, but SEC probe headline still hangs over shares

New York, Feb 24, 2026, 2:01 PM EST — Regular session rolls on.

  • AppLovin shares climbed roughly 4% during afternoon trading, after a volatile session earlier in the day.
  • U.S. software names are climbing back after a sharp selloff linked to worries over AI-driven upheaval. The bounce follows that recent swoon.
  • Reports that the SEC probe into AppLovin is still “active and ongoing” have traders on edge.

AppLovin stock rallied 4.4% to $397.23 on Tuesday as tech names snapped back, the Nasdaq-listed shares regaining ground after a stretch of heavy volatility.

This is notable: AppLovin has turned into a high-beta stand-in for two clashing bets—the “AI changes everything” optimism driving up select tech names, and the fears about AI’s impact on margins, jobs, and regulation. The result? Individual stock moves like this one pack more punch. Investing.com

For AppLovin, investors continue to weigh the potential fallout from a still-active U.S. Securities and Exchange Commission probe. What happens next, or how much risk remains on the table, isn’t clear yet.

Shares swung between $366.67 and $397.32 over the session, underlining just how sharply sentiment keeps shifting.

U.S. software stocks bounced Tuesday, reversing some of the heavy selling that’s hit the sector lately over worries about AI upending traditional business models. The main software ETF (IGV) surged, while a handful of AI-linked partners clocked notable gains.

“Software stocks, and especially the IGV, are just massively oversold right now,” said Dennis Dick, chief market strategist at Stock Trader Network. Investing.com

AppLovin faces its own unique pressure. On Feb. 20, Bloomberg said the SEC described its probe into AppLovin as “active and ongoing” in a letter, refusing to release documents because of the continuing investigation. Reuters

The SEC hasn’t alleged any misconduct by AppLovin or its leadership. Both the regulator and the company stayed silent when asked by Bloomberg, according to Reuters.

The company’s stuck handling fresh probe headlines, even as it pushes to highlight gains in its advertising unit. AppLovin, for its part, put out a first-quarter sales outlook earlier this month: $1.75 billion to $1.78 billion—topping what Wall Street was looking for, as per Reuters.

Jefferies analysts see competitive threats looming in Apple iOS ad auctions, with Meta Platforms’ aggressive bidding likely to squeeze margins, according to Reuters.

Bulls face a clear risk here: a probe might widen, carry on longer than expected, or result in enforcement or operational shifts — tough scenarios to quantify, particularly with the stock already seeing big daily moves.

Investors are waiting for either fresh word on the SEC situation—regulatory updates or any statements from the company—or the next earnings release. Investing.com pegs that report for May 13.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • S&P 500 Picks Up as AI Slide Cools, Stocks Finish June Off Lows
    June 30, 2026, 10:45 AM EDT. The S&P 500 added 0.3% to cap a weak June, with Nvidia up 1% and pressure in artificial intelligence (AI) stocks easing after earlier heavy selling tied to valuation worries. The sector's drop dragged markets early in the month. Jobs data beat, though consumer confidence stayed soft. Investors are looking for coming earnings to back up the run-up in shares. Oil ticked higher on talks over Iran and crude supply. The 10-year Treasury yield edged up to 4.39%. The DAX climbed 1.3% while major markets in Europe and Asia ended higher too.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus
Next Story

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus

Go toTop